Bone Basics™

AOR04086

Supports bone health and cartilage repair

  • Helps maintain healthy bones
  • Supports joint health and cartilage repair
Gluten Free
Non-GMO
Clear

Bone Basics is more than just a calcium supplement, it is a complete bone-building formulation that includes nutrients fundamental for maintaining mineral balance in the bone matrix and for supporting healthy joints. Bone Basics is unique because it serves not only to reduce bone loss but to maintain or even increase bone growth.

The key ingredient is microcrystalline hydroxyapatite (MCHA) complex, an extract of free-range New Zealand bovine bone (free from antibiotics and growth hormones) and a superior source of calcium and phosphorus. MCHA provides proteins, growth factors, and mucopolysaccharides that work together to stimulate bone growth and prevent bone loss. Additional nutrients include: vitamin C, vitamin D3, vitamin K2, boron, magnesium, manganese, zinc, and copper. These co-factors enhance the absorption and usage of calcium and support collagen production, which builds the framework for bone.

AOR Advantage

AOR’s Bone Basics provides the ideal source of MCHA which is pasture-fed, free-range livestock not subjected to routine antibiotics or recombinant bovine growth hormone (rBGH). This source not only ensures that the widest possible range of micronutrients survive the manufacturing process, but also provides assurances against bovine spongiform encephalopathy, commonly referred to as mad cow disease. AOR sources its MCHA from New Zealand free-range beef, where local legislation and/or custom restricts routine antibiotics and recombinant bovine growth hormone (rBGH). MCHA is a superior source of calcium and phosphorus.

NPN

80085880

Discussion

Bone Basics™ is a multi-nutrient combination designed to support bone health. It helps in the development and maintenance of teeth, cartilage and gums and helps in connective tissue formation, production and repair. It also aids in the maintenance of proper muscle function. Contains microcrystalline hydroxyapatite complex (MCHA), an extract of bovine bone derived from New Zealand pasture-fed, free-range livestock not subjected to routine antibiotics or rBGH. Calcium intake, when combined with sufficient vitamin D, a healthy diet, and regular exercise, may reduce the risk of developing osteoporosis.

Guarantee

AOR™ guarantees that all ingredients have been declared on the label. Contains no wheat, gluten, peanut, sulphite, mustard, dairy, eggs, nuts, or sesame seeds.

Adult Dosage

Take one to six capsules daily with meals a few hours before or after taking other medications, or as directed by a qualified health care practitioner.

Cautions

Consult a health care practitioner prior to use if you are pregnant or breastfeeding or taking blood thinners. This product contains corn, do not use if you have an allergy.

Disclaimer

The information and product descriptions appearing on this website are for information purposes only, and are not intended to provide or replace medical advice to individuals from a qualified health care professional. Consult with your physician if you have any health concerns, and before initiating any new diet, exercise, supplement, or other lifestyle changes.

Serving Size: Six Capsules
Calcium (from bone meal, MCHA)
900 mg
Phosphorus (from bone meal, MCHA)
407 mg
Boron (Citrate)
700 mcg
Copper (Citrate)
1000 mcg
Magnesium (Ascorbate, Citrate, Glycinate)
200 mg
Manganese (Bisglycinate)
5 mg
Zinc (Citrate)
11 mg
Vitamin C (ascorbyl palmitate, ascorbic Acid, magnesium ascorbate)
100 mg
Vitamin K2 (MK-7/MK-4)
120 mcg
Vitamin D3 (Cholecalciferol)
1000 IU (25 mcg)

Non-medicinal Ingredients: silicon dioxide, microcrystalline cellulose, starch, sucrose, arabic gum, sunflower oil, tocopherol, medium chain triglycerides, and tricalcium phosphate. Capsule: hypromellose, hydroxypropylcellulose.

Bone health
Study #1: Review article for co-supplementation of calcium and vitamin D
This report from 2017 published in Osteoporosis International, outlines the conclusions drawn from experts relating to the calcium supplementation on fracture and fall risk with and without concomitant vitamin D supplementation. The consensus opinions reached relating to calcium supplementation were in favour of combined supplementation with vitamin D particularly for high-risk groups for insufficiency. Calcium monotherapy is not recommended as there is insufficient evidence for fracture reduction. The review also dispels concerns regarding increasing cardiovascular risk with supplementation- citing insufficient evidence. The authors also recommend that patients undergoing anti-osteoporotic treatments such as bisphonates, should supplement with calcium and vitamin D rather than relying on dietary intake only.

Harvey NC, Biver E, Kaufman JM, et al. The role of calcium supplementation in healthy musculoskeletal aging: An expert consensus meeting of the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) and the International Foundation for Osteoporosis (IOF). Osteoporos Int. 2017;28(2):447-462. doi:10.1007/s00198-016-3773-6

Study#2: Bone health in children as a predictor of future risk
This double-blind, placebo-controlled, matched-pair, cluster, randomization study from 2006 examined the effects of early supplementation for minerals in school children. Given that peak bone mass is achieved through nutrition from birth to adolescence this is an important factor for the protection of adult-onset bone loss. Thus, supporting proper mineral absorption through supplementation was established in this study. School children aged 6-16 yo were given a micronutrient enriched beverage (n=146) or placebo (n=122) for 14 months. The micronutrient drink contained an additional calcium intake of 224 mg with other micronutrients- and calcium intake from diet in both groups was measured. Researchers measured various bone parameters such as bone mineral density, bone area, and BMC, using dual-energy X-ray absorptiometry at the beginning and end of the study The supplemented group had an additional increment of 22 g of WB-BMC compared with the placebo group (154 g in the supplemented group versus 132 g in the placebo group). Additionally, BMD at the neck of the femur was significantly in the supplemented group than in the placebo group. However, the supplementation did not significantly increase whole body-BMD or site-specific BMD other than the head of the femur. A follow up throughout the lives of these children to understand the impact on risk of developing bone conditions such as osteopenia or osteoporosis is warranted.

Shatrugna V, Balakrishna N, Krishnaswamy K. Effect of micronutrient supplement on health and nutritional status of schoolchildren: bone health and body composition. Nutrition. 2006;22(1 Suppl):S33-S39. doi:10.1016/j.nut.2005.07.010

Review: Nutrition and bone health

This review from 2017 highlights the importance of nutrients for bone health namely calcium and vitamin D. The review briefly covers nutrients, doses and timing that impacts bone health. Of particular interest is the explanation of when nutrient absorption is most important in bone development and protection. The review poses the theory that periods of rapid bone turnover- pregnancy, lactation, infancy, puberty, menopause, and aging are the periods where benefits of interventions (such as calcium and vitamin D supplementation and weight bearing exercise) would have the most impact. Calcium absorption efficiency also changes throughout our lives- infants consuming breastmilk absorb calcium at approximately 80% while female teens will absorb “~40% of the calcium from milk, a young woman ~30%, a middle- aged woman ~25%, and an elderly woman as low as ~5% .“ The review recommends hydroxyapatite of human bones is supplemented with complex minerals rather than single minerals- namely mineral composition of dairy products with appropriate ratios of magnesium, potassium, phosphorus, B vitamins, and protein.

Weaver CM. Nutrition and bone health. Oral Dis. 2017;23(4):412-415. doi:10.1111/odi.12515

Study #3: Bone Health in Menopausal women
The SWAN study is a multicenter, multiethnic longitudinal study that observed 1490 women from 42-52 yo over 12 years published in 2019. The purpose of the study was to determine if a correlation between calcium supplementation and reduced risk of bone fracture and BMD exists. Researchers found that there was no significant difference in bone mineral density of early perimenopausal women calcium supplement use did have a protective association in premenopausal women. However, there was less annual bone loss at the femoral neck and lumbar spine with supplementation. Further there was no significant difference in relative risk of fracture in any menopausal group. It is important to note however, calcium supplement users had higher risk factors for fracture- ie. more likely to have experienced a prior fracture(s), have lower BMI and BMD, and be of Caucasian descent. Thus the researchers point out that supplementation may have been due to the increased fracture risk and confounds results somewhat. Further, dosing of calcium was not standardized as this was not a randomized controlled trial.

Bailey RL, Zou P, Wallace TC, et al. Calcium Supplement Use Is Associated With Less Bone Mineral Density Loss, But Does Not Lessen the Risk of Bone Fracture Across the Menopause Transition: Data From the Study of Women’s Health Across the Nation. JBMR Plus. 2019;4(1):e10246. Published 2019 Nov 15. doi:10.1002/jbm4.10246

Study #4: Trace minerals in bone health- beyond just calcium
This review from 2013 highlights the importance of not just calcium and vitamin D but other trace minerals in bone health. The role of zinc, copper, magnesium, manganese, iron, boron, selenium as osteoprotective was highlighted.
Zinc: benefits for bone related to the inhibition of osteoclastic bone resorption. A study showing that zinc is able to slow the loss of spinal bone in postmenopausal women supplemented with zinc in a mixture with manganese and copper compared to women who used only calcium. Zinc can also offset the adverse effects of heavy metals such as lead and cadmium which can impact osteoblast function.
Copper: protects bone by activating lysine mediated collagen and elastin crosslinking which fortifies bone.
Magnesium: important for the production of hydroxyapatite, vitamin D, PTH, thereby maintaining structural integrity and calcium absorption.
Manganese: This mineral is important in the stimulation of bone matrix synthesis and by activation of somatomedin. Further, since decline in estrogen levels is also associated with manganese deposition, post-menopausal women may be at risk for manganese depletions.
Boron: Is involved in calcium metabolism, bone growth, 1,25(OH)2 D3 vitamin, testosterone and estradiol [45] modulating bone remodeling and increases bone stiffness.
Selenium: Selenium deficiency was related to increased bone resorption and had detrimental effects on bone microarchitecture

Zofková I, Nemcikova P, Matucha P. Trace elements and bone health. Clin Chem Lab Med. 2013;51(8):1555-1561. doi:10.1515/cclm-2012-0868